Format

Send to

Choose Destination
Pigment Cell Melanoma Res. 2009 Apr;22(2):175-86. doi: 10.1111/j.1755-148X.2009.00554.x. Epub 2009 Feb 14.

The good and the bad of chemokines/chemokine receptors in melanoma.

Author information

1
Department of Veterans Affairs and Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN, USA. ann.richmond@vanderbilt.edu

Abstract

Chemokine ligand/receptor interactions affect melanoma cell growth, stimulate or inhibit angiogenesis, recruit leukocytes, promote metastasis, and alter the gene expression profile of the melanoma associated fibroblasts. Chemokine/chemokine receptor interactions can protect against tumor development/growth or can stimulate melanoma tumor progression, tumor growth and metastasis. Metastatic melanoma cells express chemokine receptors that play a major role in the specifying the organ site for metastasis, based upon receptor detection of the chemokine gradient elaborated by a specific organ/tissue. A therapeutic approach that utilizes the protective benefit of chemokines involves delivery of angiostatic chemokines or chemokines that stimulate the infiltration of cytotoxic T cells and natural killer T cells into the tumor microenvironment. An alternative approach that tackles the tumorigenic property of chemokines uses chemokine antibodies or chemokine receptor antagonists to target the growth and metastatic properties of these interactions. Based upon our current understanding of the role of chemokine-mediated inflammation in cancer, it is important that we learn to appropriately regulate the chemokine contribution to the tumorigenic 'cytokine/chemokine storm', and to metastasis.

PMID:
19222802
PMCID:
PMC2848967
DOI:
10.1111/j.1755-148X.2009.00554.x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center